Pricing Log in Create free account

BioLineRx Ltd. (BLRX) vs Lisata Therapeutics, Inc. (LSTA)

BioLineRx Ltd. and Lisata Therapeutics, Inc. are both Biotechnology companies. BioLineRx Ltd. and Lisata Therapeutics, Inc. are of similar size ($10.2M and $9.6M). Lisata Therapeutics, Inc. grew revenue faster over the last twelve months: −24.7% against −91.9%. Lisata Therapeutics, Inc. has the higher net margin (0.00% vs −502.1%) and the higher return on invested capital (0.00% vs −74.3%). Across the 17 metrics below, Lisata Therapeutics, Inc. leads on 10 and BioLineRx Ltd. on 7.

Valuation

Metric BLRX LSTA Biotechnology median
P/E n/m n/m 8.50
P/S 6.51 0.62 9.71
P/B 0.55 1.17 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.93 0.14 9.21
Earnings yield (82.84%) (159.22%) (33.15%)
Free cash flow yield (119.61%) (131.69%) (25.50%)

Profitability

Metric BLRX LSTA Biotechnology median
Gross margin 80.03% 0.49% 65.16%
Operating margin (874.28%) 0.00% 0.00%
Net margin (502.08%) 0.00% 0.00%
Free cash flow margin (776.29%) 0.00% 0.00%
Return on equity (38.10%) (101.66%) (56.36%)
Return on assets (18.21%) (80.81%) (48.04%)
Return on invested capital (74.28%) 0.00% 0.00%

Growth

Metric BLRX LSTA Biotechnology median
Revenue growth (TTM) (91.93%) (24.67%) 6.02%
EPS growth (last fiscal year) 93.72% 20.42% 30.26%
Revenue growth, 5-year CAGR — (20.28%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLRX LSTA Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.20 3.69 4.72
Net debt to EBITDA 1.22 0.88 0.96

Dividend

Metric BLRX LSTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BLRX LSTA Biotechnology median
Market cap 10.21m 9.64m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack